Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons

Annals of Internal Medicine

Volumn 119, Issue 3, 1993, Pages 185-193

  Markowitz, Norman ^a   Hansen, Nellie I ^a   Wilcosky, Timothy C ^a   Hopewell, Philip C ^a   Glassroth, Jeffrey ^a   Kvale, Paul A ^a   Mangura, Bonita T ^b   Osmond, Dennis ^a   Wallace, Jeanne M ^c   Rosen, Mark J ^d   Reichman, Lee B ^b  

^a University Hospital 1354 ^*

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c OLIVE VIEW UCLA MEDICAL CENTER   (United States)

^d BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CANDIDA ANTIGEN; CD4 ANTIGEN; MUMPS VACCINE; TUBERCULIN;

ADULT; AGED; ARTICLE; BCG VACCINATION; CLONAL ANERGY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DISEASE COURSE; DRUG DEPENDENCE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TUBERCULIN TEST; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; ANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HIV SEROPOSITIVITY; HOMOSEXUALITY; HUMAN; HYPERSENSITIVITY, DELAYED; INTRADERMAL TESTS; LEUKOCYTE COUNT; MALE; MIDDLE AGE; PROSPECTIVE STUDIES; SUBSTANCE ABUSE, INTRAVENOUS; SUPPORT, U.S. GOV'T, P.H.S.; TUBERCULIN TEST;

EID: 0027518101     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-119-3-199308010-00002     Document Type: Article

References (41)

1. Pitchenik AE, Cole C, Russell BW, Fischl M-V, Spira TJ, Snider DE Jr. Tuberculosis, atypical mycobacteriosis, and the acquired immunodeficiency syndrome among Haitian and non-Haitian patients in South Florida. Ann Intern Med. 1984;101:641-5.
2. Maayan S, Wormser GP, Hewlett D, Miller SN, Duncanson FP, Rodriguez A, et al. Acquired immunodeficiency syndrome (AIDS) in an economically disadvantaged population. Arch Intern Med. 1985; 145:1606-12.
3. Tuberculosis and the acquired immunodeficiency syndrome-New York City. MMWR. 1987;36:785-90,795.
4. Rieder HL, Cauthen GM, Block AB, Cole CH, Holtzman D, Snider DE Jr, ef al. Tuberculosis and the acquired immunodeficiency syndrome-Florida, Arch Intern Med. 1989;149:1268-73.
5. Rieder HL, Cauthen GM, Kelly GD, Bloch AB, Snider DE Jr. Tuberculosis in the United States. JAMA. 1989;262:385-9.
6. Barnes PF, Bloch AB, Davidson PT, Snider DE Jr. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med. 1991;324:1644-50.
7. Jereb JA, Kelly GD, Dooley SW Jr, Cauthen GM, Snider DE Jr. Tuberculosis morbidity in the United States: final data, 1990. MMWR CDC Surveill Summ. 1991;40:23-7.
8. Prevention and control of tuberculosis in U.S. communities with at-risk minority populations. MMWR. 1992;41(RR-5):1-I1.
9. Di Perri G, Cruciani M, Danzi MC, Luzzati R, De Checci G, Malena M, et al, Nosocomial epidemic of active tuberculosis among HIV-infected patients. Lancet. 1989;2:1502-4,
10. Transmission of multidrug-resistant tuberculosis from an HIV-positive client in a residential substance-abuse treatment facility - Michigan. MMWR. 1991;40:1291-31.
11. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons-Florida and New York, 1988-1991. MMWR. 1991;40:585-91.
12. Daley CL, Small PM, Scheeter GF, Schoolnik GK, McAdam RA, Jacobs WR, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency syndrome: an analysis using restriction-fragment-fenglh polymorphisms. N Engl J Med. 1992;326:231-5.
13. Edlin BR, Tokars JI, Grieco MH, Crawford JT, Williams J, Sordillo EM, et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med. 1992;326:1514-21.
14. Screening for tuberculosis and tuberculous infection in high-risk populations: Recommendations of the Advisory Committee for Elimination of Tuberculosis. MMWR, 1990;39:1-7.
15. Sears SD, Fox R, Brookmeyer R, Leavitt R, Polk BF. Delayed hypersensitivity skin testing and anergy in a population of gay men. Clin Immunol Immunopathol. 1987;45:177-83.
16. Colebunders RL, Lebughe I, Szila N, Kalunga D, Francis H, Ryder R, et al. Cutaneous deiayed-type hypersensitivity in patients with human immunodeficiency virus infection in Zaire, J Acquir Immune Defie Syndr. 1989;2:576-8.
17. Marion SA, Scheeler MT, Weaver MS, McCleod WA, Boyko WJ, Walloughby B, et al. Evidence that prior immune dysfunction predisposes to human immunodeficiency virus infection in homosexual men. J Acquir Immune Defic Syndr. 1989;2:178-86,
18. Graham NM, Nelson KE, Solomon L, Bonds M, Rizzo RT, Scavotto J, et al. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users, JAMA. 1992;267:369-73.
19. Purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis. MMWR. 1991;40:273-33,
20. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases. MMWR. 1987;36:1S-15S.
21. Palmer DL, Reed WP. Delayed hypersensitivity skin testing. I. Response rates in a hospitalized population. J Infect Dis. 1974;130: 132-7.
22. Giorgi JV, Sheng HL, Margolick JR, Bauer KD, Ferbas J, Waxdal M, et al. Quality control in the flow cytometric measurement of T-lymphocyte subsets: The Mutticenter AIDS Cohort Study (MACS) experience. Clin Immunol Immutsopathol. 1990;55:173-86.
23. Fleiss JL. Statistical Methods For Rates And Proportions. New York: John Wiley and Sons;1981.
24. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
25. Zeger SL, Liang KY. Longitudinal dala analysis for discrete and continuous outcomes. Biometrics. 1986;42:121-30.
26. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: John Wiley and Sons;1989.
27. Comstock GW. Epidemiology of tuberculosis. Am Rev Respir Dis. 1982;125:8-15.
28. Smith DT. Diagnostic and prognostic significance of the quantitative tuberculin tests. The influence of subclinical infections with atypical mycobacteria. Ann Intern Med, 1967;67:919-46.
29. Snider BE Jr. The tuberculin skin test. Am Rev Respir Dis. 1982; 125:108-18.
30. Johnson MP, Coberly JS, Clermont HC, Chaisson RE, Davis HL, Losikoff P, et al. Tuberculin skin test reactivity among adults infected with human immunodeficiency virus. J Infect Dis. 1992;166: 194-8.
31. Canessa PA, Fasano L, Lavecchia MA, Torraca A, Schiattone ML. Tuberculin skin test in asymptomatic HIV seropositive carriers [Letter]. Chest. 1989;96:1215-6.
32. Robert CF, Hirschel B, Rochat T, Deglon JJ. Tuberculin skin reactivity in HIV-seropositive intravenous drug addicts. N Engl J Med. 1989;321:1268.
33. Tuberculin reactions in apparently healthy HIV-seropositive and HIV-seronegative women - Uganda. MMWR. 1990;39:638-9, 645-6.
34. Small PM, Schecter GF, Goodman PC, Sande MA, Chaisson RE, Hopewell PC. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med. 1992;324: 289-94.
35. Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med. 1989;320:545-50.
36. Selwyn PA, Sckell BM, Alcabes P, Friedland GH, Klein RS, Schoenbaum EE. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA. 1992;268:504-9.
37. Kent DC, Schwartz R. Active pulmonary tuberculosis with negative luberculin skin reactions. Am Rev Respir Dis. 1967;95:411-8.
38. Holden M, Dubin MR, Diamond PH. Frequency of negative intermediate-strength tuberculin sensitivity its patients with active tuberculosis. N Engl J Med. 1971;85:1506-9.
39. Nash DR, Douglass JE. Anergy in active pulmonary tuberculosis. A comparison between positive and negative reactors and an evaluation of 5 TU and 250 TU skin test doses. Chest. 1980;77:32-7.
40. Jordan TJ, Lewit EM, Montgomery RL, Reichman LB. Isoniazid as preventive therapy in HIV-infected intravenous drug users. JAMA. 1991;265:2987-91.
41. Huebner RE, Villarino ME, Snider DE Jr. Tuberculin skin test testing and the HIV epidemic. JAMA. 1992;267:409-10.